ID   COLO 60H
AC   CVCL_4572
SY   COLO-60H; Colo-60H; COLO60H
DR   CLS; 300456
DR   GEO; GSM1448094
DR   Wikidata; Q54814127
RX   PubMed=25926053;
CC   HLA typing: A*02:01 (CLS=300456).
CC   Microsatellite instability: Instable (MSI) (PubMed=25926053).
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Colon, transverse; UBERON=UBERON_0001157.
ST   Source(s): CLS=300456; PubMed=25926053
ST   Amelogenin: X,Y
ST   CSF1PO: 11,15
ST   D13S317: 11
ST   D16S539: 9,13
ST   D18S51: 13,15
ST   D19S433: 12,13
ST   D21S11: 29,33.2
ST   D2S1338: 21,24
ST   D3S1358: 15,16,17
ST   D5S818: 9,16
ST   D7S820: 7.3,10
ST   D8S1179: 11
ST   FGA: 21,24
ST   Penta D: 14
ST   Penta E: 11,13
ST   TH01: 6,9.3
ST   TPOX: 7,10
ST   vWA: 15,16,17,19
DI   NCIt; C4349; Colon adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 02-05-24; Version: 18
//
RX   PubMed=25926053; DOI=10.1038/ncomms8002;
RA   Medico E., Russo M., Picco G., Cancelliere C., Valtorta E., Corti G.,
RA   Buscarino M., Isella C., Lamba S., Martinoglio B., Veronese S.,
RA   Siena S., Sartore-Bianchi A., Beccuti M., Mottolese M.,
RA   Linnebacher M., Cordero F., Di Nicolantonio F., Bardelli A.;
RT   "The molecular landscape of colorectal cancer cell lines unveils
RT   clinically actionable kinase targets.";
RL   Nat. Commun. 6:7002.1-7002.10(2015).
//